These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3051991)

  • 1. Metabolic effects of antihypertensive therapy with a calcium antagonist.
    Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; DiPette DJ; Evans RR
    Am J Cardiol; 1988 Oct; 62(11):109G-113G. PubMed ID: 3051991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
    Pool PE; Seagren SC; Salel AF
    Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sustained-release diltiazem on blood pressure and serum lipids: a multicenter, randomized, placebo-controlled study.
    Djian J; Fermé I; Zannad F; Chaignon M; Asmar R
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S38-45. PubMed ID: 1706012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Lakshman MR; Reda DJ; Materson BJ; Cushman WC; Freis ED
    Arch Intern Med; 1999 Mar; 159(6):551-8. PubMed ID: 10090111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.
    Pollare T; Lithell H; Mörlin C; Präntare H; Hvarfner A; Ljunghall S
    J Hypertens; 1989 Jul; 7(7):551-9. PubMed ID: 2668407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
    Lacourcière Y; Poirier L; Boucher S; Spenard J
    J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
    Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
    Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
    Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
    Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release diltiazem: duration of antihypertensive effect.
    Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; Dipette DJ; Evans RR
    J Clin Pharmacol; 1989 Jun; 29(6):533-7. PubMed ID: 2666454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
    Frishman WH; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H; Smith LK; Sowers J; Swartz S; Zawada E
    Am J Cardiol; 1985 Dec; 56(16):92H-96H. PubMed ID: 3907323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
    Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M; Martell Claros N;
    Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension.
    Nikkilä MT; Inkovaara JA; Heikkinen JT; Olsson SO
    Am J Cardiol; 1989 May; 63(17):1227-30. PubMed ID: 2711992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
    Ollivier JP; Wajman A; Stalla-Bourdillon A
    Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
    Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
    Carré A; Joire JE; Mounier-Vehier C; Lequeuche B
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension.
    Hanefeld M; Abletshauser C
    J Int Med Res; 2001; 29(4):270-9. PubMed ID: 11675899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
    Myburgh DP; Gordon NF
    Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.